Avadel Pharma (AVDL) Misses Q2 EPS by 65c

Avadel Pharma (NASDAQ: AVDL) reported Q2 EPS of ($1.07), $0.65 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Avadel Pharma (AVDL) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand